Project description
Technology platforms for health advancements
To enable affordable healthcare in an aging society, healthcare is moving from centralised symptomatic treatment towards preventive, predictive and participatory care. E-health will provide solutions for a wide range of health-related societal challenges. The EU-funded project HELoS will support this initiative and accelerate innovation in medical devices, opening technology platforms and standards, moving away from the inflexible and costly point solutions that presently dominate electronic medical device manufacturing. Open technology platforms supported by roadmaps will generate the production volumes needed for sustained technology development, resulting in new and better solutions in the healthcare domain.
Objective
The objective of the HELoS CSA is to support the Health.E Lighthouse Initiative Advisory Service (LIASE) in its ambition to accelerate innovation in medical devices (“Moore for Medical”).
Health.E will accelerate the innovation in medical devices and systems by stimulating the development of open technology platforms and standards , thereby moving away from the inflexible and costly point solutions that presently dominate electronic medical device manufacturing.
Open technology platforms, supported by roadmaps, will generate the production volumes needed for sustained technology development, resulting in new and better solutions in the healthcare domain.
Health.E will:
• Translate the needs of medtech and pharma into ECS opportunities;
• Build on the ECS Strategic Research Agenda and identify the gaps;
• Stimulate initiatives:
towards open technology platforms and standards for medical devices;
to anticipate the requirements for regulatory, Notified Bodies, clinical trials and market access;
to better apply to the current care practices, necessary conditions for market access.
• Connect to European initiatives and relevant communities including PPPs such as ECSEL, IMI, Eureka, and relevant industry associations
In the HELoS CSA, three main components are identified that need to be connected in order to address the complex issue of innovation in the medical industry:
• Connecting existing networks: ECSEL projects, (inter)national and regional projects and initiatives;
• Addressing and connecting scientific/technical issues and non-technical aspects e.g. legal, regulatory, standardization, ethical, economic (cross-cutting issues);
• Extending the network of stakeholders and markets across Europe (spreading excellence, facilitating international collaboration, new applications);
• The dissemination of the results of this initiative to the stakeholders and the general public.
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.2.1.1.7. - ECSEL
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
CSA - Coordination and support action
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-ECSEL-2019-3-CSA-Health-E-one-stage
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
2628 CN DELFT
Netherlands
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.